Literature DB >> 35776537

Joined at the hip: The role of light chain complementarity determining region 2 in antibody self-association.

Paul R Sargunas1, Jamie B Spangler1,2,3,4,5,6,7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35776537      PMCID： PMC9282379          DOI： 10.1073/pnas.2208330119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   12.779


× No keyword cloud information.
  25 in total

1.  Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies.

Authors:  G Müller-Newen; A Küster; J Wijdenes; F Schaper; P C Heinrich
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

2.  The diversity of H3 loops determines the antigen-binding tendencies of antibody CDR loops.

Authors:  Yuko Tsuchiya; Kenji Mizuguchi
Journal:  Protein Sci       Date:  2016-01-20       Impact factor: 6.725

3.  Selection of antibodies that regulate phenotype from intracellular combinatorial antibody libraries.

Authors:  Hongkai Zhang; Ian A Wilson; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-10       Impact factor: 11.205

Review 4.  Monoclonal antibodies: technologies for early discovery and engineering.

Authors:  Patrick J Kennedy; Carla Oliveira; Pedro L Granja; Bruno Sarmento
Journal:  Crit Rev Biotechnol       Date:  2017-08-08       Impact factor: 8.429

5.  Enhanced apoptosis and tumor regression induced by a direct agonist antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2.

Authors:  Kazuhiro Motoki; Eiji Mori; Atsushi Matsumoto; Mayumi Thomas; Takafumi Tomura; Robin Humphreys; Vivian Albert; Mari Muto; Hitoshi Yoshida; Masami Aoki; Taro Tamada; Ryota Kuroki; Hideaki Yoshida; Isao Ishida; Carl F Ware; Shiro Kataoka
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

Review 6.  The promise and challenges of immune agonist antibody development in cancer.

Authors:  Patrick A Mayes; Kenneth W Hance; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2018-06-15       Impact factor: 84.694

7.  Complement is activated by IgG hexamers assembled at the cell surface.

Authors:  Christoph A Diebolder; Frank J Beurskens; Rob N de Jong; Roman I Koning; Kristin Strumane; Margaret A Lindorfer; Marleen Voorhorst; Deniz Ugurlar; Sara Rosati; Albert J R Heck; Jan G J van de Winkel; Ian A Wilson; Abraham J Koster; Ronald P Taylor; Erica Ollmann Saphire; Dennis R Burton; Janine Schuurman; Piet Gros; Paul W H I Parren
Journal:  Science       Date:  2014-03-14       Impact factor: 47.728

8.  Facile discovery of surrogate cytokine agonists.

Authors:  Michelle Yen; Junming Ren; Qingxiang Liu; Caleb R Glassman; Timothy P Sheahan; Lora K Picton; Fernando R Moreira; Arjun Rustagi; Kevin M Jude; Xiang Zhao; Catherine A Blish; Ralph S Baric; Leon L Su; K Christopher Garcia
Journal:  Cell       Date:  2022-03-23       Impact factor: 66.850

9.  Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands.

Authors:  Ignacio Moraga; Gerlinde Wernig; Stephan Wilmes; Vitalina Gryshkova; Christian P Richter; Wan-Jen Hong; Rahul Sinha; Feng Guo; Hyna Fabionar; Tom S Wehrman; Peter Krutzik; Samuel Demharter; Isabelle Plo; Irving L Weissman; Peter Minary; Ravindra Majeti; Stefan N Constantinescu; Jacob Piehler; K Christopher Garcia
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

Review 10.  Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods.

Authors:  Emily K Makowski; Lina Wu; Priyanka Gupta; Peter M Tessier
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.